Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Flownamics is a private life science tools and bioprocess automation company that develops automated sampling, cell-free sampling, liquid handling, and analytical integration systems for bioreactor and fermentation workflows. The company serves biotechnology and biopharmaceutical process development and manufacturing teams across upstream and downstream applications. Its core offerings include the Seg-Flow automated sampling platform, FISP cell-free sampling probes, fraction collection systems, feeding and dispensing modules, and integrations with third-party analytical instruments such as Raman and cell analysis systems. Flownamics markets its technology as a way to improve process consistency, reduce manual intervention, and enable at-line and online bioprocess monitoring. The business appears to be primarily a commercial instrumentation supplier rather than a therapeutic developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Flownamics Analytical Instruments.